VIVAN Life Sciences Blog
Suven Life Sciences gets patents for neuro-degenerative drug
Pharmaceutical firm Suven Life SciencesBSE 0.45 % has been granted a patent each by Eurasia and Israel for drug used in the treatment of neuro-degenerative diseases.
Neuro-degenerative ailments include Alzheimer’s disease, Schizophrenia and Parkinson’s disease.
In a BSE filing, the company said it has received “grant of one product patent from Eurasia and one product patent from Israel corresponding to the New Chemical Entities (NCEs) for the ..
